Skip to main content
OpenTrials

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

NCT06317662

Conditions
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 113 locations
View Trial Details
Recruiting

Long-term Follow up Local Registry Study of Kymriah in South Korea

NCT06785818

Conditions
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Gyeonggi-do, Korea, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
View all 18 locations
View Trial Details
Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT06124157

Conditions
B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 155 locations
View Trial Details
Recruiting

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

NCT07570173

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Rigshospitalet ( Site 0802) Copenhagen, Capital Region, Denmark
  • Aarhus Universitetshospital. Hæmatologisk afdeling ( Site 0804) Aarhus Nord, Central Jutland, Denmark
  • Odense Universitetshospital ( Site 0801) Odense, Region Syddanmark, Denmark
  • Rambam Health Care Campus ( Site 0903) Haifa, Israel
View Trial Details
Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

NCT03739814

Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 278 locations
View Trial Details
Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
Locations
  • Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
  • Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
  • Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
View all 71 locations
View Trial Details
Recruiting

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

NCT06764238

Conditions
Acute Lymphoblastic Leukemia ALL, B Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt Lymphoma, +21 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
View all 27 locations
View Trial Details
Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

NCT07069699

Conditions
Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details

Related conditions